| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/17/2009 | CA2340934C Novel collectin |
| 02/17/2009 | CA2316411C Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 02/17/2009 | CA2236455C Human p27kip1 gene promoter |
| 02/17/2009 | CA2192260C Dna fragment encoding a protein involved in fatty aldehyde decarbonylase activity, recombinant molecules comprising said fragment and a method for obtaining transformed bacterial cells and plants |
| 02/17/2009 | CA2180957C Cloning and recombinant production of crf receptor(s) |
| 02/17/2009 | CA2164984C Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
| 02/17/2009 | CA2138928C Immunoconjugates |
| 02/17/2009 | CA2121498C Recombitope peptides |
| 02/17/2009 | CA1341591C Detoxification of pertussis toxin |
| 02/15/2009 | CA2628900A1 Monoclonal antibodies against .beta.3 integrins |
| 02/12/2009 | WO2009021191A2 Improved t7 expression system |
| 02/12/2009 | WO2009020923A1 Human monoclonal antibodies and methods for producing the same |
| 02/12/2009 | WO2009020645A2 Matriptase protein and uses thereof |
| 02/12/2009 | WO2009020389A1 Culture medium for eukaryotic cells |
| 02/12/2009 | WO2009020144A1 Method of producing heterogeneous protein |
| 02/12/2009 | WO2008128144A3 Monoclonal antibody selecting system, and making and using thereof |
| 02/12/2009 | WO2008094546A3 Genetically modified host cells for increased p450 activity levels and methods of use thereof |
| 02/12/2009 | WO2006055077A3 Modulation of cd4+ t cell responses by a tick saliva protein, salp15 and polypeptides derived therefrom |
| 02/12/2009 | WO2005086798A3 Improved interleukin-2 muteins |
| 02/12/2009 | US20090043076 Modified interferon beta with reduced immunogenicity |
| 02/12/2009 | US20090042830 Novel oncogene, recombinant protein derived therefrom, and uses thereof |
| 02/12/2009 | US20090042809 Blood Pressure Lowering Protein Hydrolysates |
| 02/12/2009 | US20090042797 Gamma-heregulin |
| 02/12/2009 | US20090042796 Derivatives of the il-2 receptor gamma chain, their production and use |
| 02/12/2009 | US20090042794 Group b streptococcus antigens and corresponding dna fragments |
| 02/12/2009 | US20090042792 18 human secreted proteins |
| 02/12/2009 | US20090042787 Proteolytically cleavable fusion proteins with high molar specific activity |
| 02/12/2009 | US20090042786 Kunitz-type recombinant inhibitor |
| 02/12/2009 | US20090042780 Modified TGF-Beta Superfamily Polypeptides and Related Methods |
| 02/12/2009 | US20090042777 G-CSF Transferrin Fusion Proteins |
| 02/12/2009 | US20090042776 Fungal immunomodulatory protein (fip) prepared by microorganisms and uses thereof |
| 02/12/2009 | US20090042775 Functional genomics, bioinformatics |
| 02/12/2009 | US20090042277 Nucleic acids encoding recombinant soluble endoproteases |
| 02/12/2009 | US20090042270 Activatable recombinant neurotoxins |
| 02/12/2009 | US20090042254 Expression of soluble antibody fragment by truncation of ch1 domain |
| 02/12/2009 | US20090042253 Use of perfusion to enhance production of fed-batch cell culture in bioreactors |
| 02/12/2009 | US20090042252 Interferon-alpha polypeptides and conjugates |
| 02/12/2009 | US20090042251 Chimeric fusion protein |
| 02/12/2009 | US20090042250 Methods and compositions for inactivating alpha 1,6 fucosyltransferase (FUT8) gene expression |
| 02/12/2009 | US20090042249 Vectors for Cloning |
| 02/12/2009 | US20090042248 Folded recombinant catalytic fragments of multidomain serine proteases, preparation and uses thereof |
| 02/12/2009 | US20090042247 N-acetylglucosaminyltransferase vb coding sequences, recombinant cells and methods |
| 02/12/2009 | US20090042246 Methods For The Production And Secretion Of Modified Peptides |
| 02/12/2009 | US20090042245 Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
| 02/12/2009 | US20090042244 Protein expression yield enhancement in cell-free protein synthesis systems by addition of antifoam agents |
| 02/12/2009 | US20090042216 Method for purifying proteins and/or biomolecule or protein complexes |
| 02/12/2009 | US20090042212 Detection of primary infections with pathogens |
| 02/12/2009 | US20090042199 Nucleotide sequences coding lymphocyte adhesion protein for use in treatment of autoimmunity, inflammation and infection |
| 02/12/2009 | US20090041899 Recombinant hexose oxidase, a method of producing same and use of such enzyme |
| 02/12/2009 | US20090041896 Use in treatment of paper pulp or animal feeds; enzyme is active over a wide range of temperature and of basic and acid pH |
| 02/12/2009 | US20090041796 Surface protein of leptospira |
| 02/12/2009 | US20090041794 Identification of Hla-A2-Presented T-Cell Epitopes Derived from the Oncofoetal Antigen-Immature Laminin Receptor Protein and Uses Thereof |
| 02/12/2009 | US20090041784 Compositions and methods relating to glucagon receptor antibodies |
| 02/12/2009 | US20090041783 Anti-platelet membrane glycoprotein vi monoclonal antibody |
| 02/12/2009 | US20090041782 Novel serotype streptococcus mutans and utilization of the same |
| 02/12/2009 | US20090041766 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 02/12/2009 | US20090041762 Methods of treating ankylosing spondylitis using anti-TNF antibodies and peptides of human tumor necrosis factor |
| 02/12/2009 | US20090041761 Method of immunizing animal, composition for immunization, method for producing antibody, method for producing hybridoma and method for producing monoclonal antibody |
| 02/12/2009 | US20090041742 Human dnase ii |
| 02/12/2009 | US20090041717 High affinity human antibodies to human nerve growth factor |
| 02/12/2009 | US20090041692 Methods of producing lignin peroxidase and its use in skin and hair lightening |
| 02/12/2009 | US20090041660 new monoclonal antibodies and binding fragments which recognize and immunoreact with cell surface antigens found on small cell lung cancer (SCLC) cells; antibodies have tumor specificity and are useful for therapy, diagnosis, monitoring, detecting and imaging of SCLC disease |
| 02/12/2009 | US20090041659 Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse |
| 02/12/2009 | DE102004059357B4 Antikörper, welcher die Interaktion von humanem Thy-1 und dessen Liganden blockiert, sowie dessen Verwendung Antibody that blocks the interaction of human Thy-1 and its ligands, and its use |
| 02/12/2009 | CA2695849A1 Method of producing heterogeneous proteins |
| 02/11/2009 | EP2022855A1 High secretion production method of protein |
| 02/11/2009 | EP2022854A1 Phage-displaying single-chain antibody capable of recognizing non-reduced mannose residue |
| 02/11/2009 | EP2022799A2 Polycistronic expression of antibodies |
| 02/11/2009 | EP2021489A2 Codon optimization method |
| 02/11/2009 | EP2021466A1 Cloning and expression of a novel phytase |
| 02/11/2009 | EP2021370A1 Trail receptor-binding agents and uses of the same |
| 02/11/2009 | EP2021366A2 Production of proteins carrying oligomannose or human-like glycans in yeast and methods use thereof |
| 02/11/2009 | EP2021360A1 CYCLODIPEPTIDE SYNTHETASE AND ITS USE FOR SYNTHESIS OF CYCLO(TYR-Xaa) CYCLODIPEPTIDES |
| 02/11/2009 | EP2021357A1 Cyclodipeptide synthetases and their use for synthesis of cyclo(leu-leu) cyclodipeptide |
| 02/11/2009 | EP1910414A4 Polynucleotides and polypeptides of the il-12 family of cytokines |
| 02/11/2009 | EP1636340A4 Unnatural reactive amino acid genetic code additions |
| 02/11/2009 | EP1444367B1 Reca-negative and rhab-negative microorganism |
| 02/11/2009 | EP1109577B1 Multicomponent vaccines against Staphylococcus aureus |
| 02/11/2009 | EP1042466B1 Polypeptides, polynucleotides and uses thereof |
| 02/11/2009 | EP0946731B1 Non-m non-o hiv strains, fragments and applications |
| 02/11/2009 | EP0784059B1 Polynucleotides encoding an antigenic polypeptide of chlamydia pneumoniae |
| 02/11/2009 | CN101365799A Method for preparing antibodies selective for activating Fc receptors |
| 02/11/2009 | CN101365785A Process and materials for production of glucosamine and n-acetylglucosamine |
| 02/11/2009 | CN101365721A Methods for cyclic nucleotide determination |
| 02/11/2009 | CN101365712A Pan-her antagonists and methods of use |
| 02/11/2009 | CN101363040A Method for preparing collagen protein |
| 02/11/2009 | CN101363039A Extraction method of alfalfa leaf protein |
| 02/11/2009 | CN101363029A Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex DNA |
| 02/11/2009 | CN101361972A Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component |
| 02/11/2009 | CN100460516C Collagen wet-retaining face mask and preparation process thereof |
| 02/11/2009 | CN100460510C Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies |
| 02/11/2009 | CN100460509C Trichina paramyosin gene and application thereof |
| 02/11/2009 | CN100460508C Secretory expression for human insulin gene in methyl alcohol yeast |
| 02/11/2009 | CN100460502C Genetically engineered bacteria for efficiently expressing recombinant human sweet gland antibacterial peptide, and constructing method and use thereof |
| 02/10/2009 | US7488814 Polynucleotides, expression vectors, host cells, biosynthesis of polypeptides, generating antibody responses |
| 02/10/2009 | US7488807 Monoclonal antibody for detecting staphylococcal infection |
| 02/10/2009 | US7488806 Blocks binding to Notch receptor; surface plasmon resonance; pathological vascularization associated with tumor angiogenesis and cancer, immunodeficiency diseases, transplant rejection, or inflammation; and neurodegenerative conditions, e.g., associated with prion disease |
| 02/10/2009 | US7488805 Apoptosis proteins |
| 02/10/2009 | US7488804 Immunotherapy for the treatment of type I hypersensitivity-mediated disease or autoimmune disease; polypeptide sequence |
| 02/10/2009 | US7488803 Anticancer agents; two primordial germ cell-specific expressed genes, Fragilis and Stella; as markers for primordial germ cells |